The Indiana Alzheimer Disease Center is committed to supporting the National Alzheimer’s Project Act (NAPA), an initiative to lead research to prevent and effectively treat Alzheimer’s disease by 2025.
Advanced Technology and Collaboration
Resources available to researchers at the center include healthy and affected participants and donations from deceased individuals for studies. Specifically, the center has biological specimens, including DNA, RNA, plasma, serum, CSF and PBMC; brain tissue and other post-mortem specimens from individuals affected by Alzheimer’s disease characterized neuropathologically, radiologic images and data extracted from processing of these images; and data acquired from Indiana Alzheimer Disease Center subjects, including demographic, psychosocial, psychiatric, neurological, neuropsychological, neuroradiological, biochemical, genetic and neuropathological information.
Fellowships and Open Positions
Fellowships and NIA-funded pilot projects are available from investigators who work for the Indiana Alzheimer’s Disease Center.